Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils.

Eur J Cell Biol

Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia.

Published: August 1996

Directed locomotion of mouse peritoneal neutrophils under agarose was studied, and activity of hydrogen peroxide (H2O2) as a chemoattractant was tested in its concentration range of 10(-6) to 10(-3) M. It has been found that H2O2 at low concentrations (about 10 microM) induces chemotactic activity. This activity was not affected by the presence of serum in the agarose medium. Use of bovine serum albumin instead of the heat-inactivated bovine serum in the medium had no effect on cell locomotion. The H2O2-induced chemotaxis was significantly reduced by catalase. Involvement of [Ca2+]i transients in the H2O2-induced chemotactic response was shown. These data indicate that H2O2 itself in small quantities can act as a chemoattractant without interacting with a plasma precursor to form a chemotactic factor. It has been suggested that H2O2 may form an important link similar to the second messenger in communication between the cells.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mouse peritoneal
8
peritoneal neutrophils
8
bovine serum
8
hydrogen peroxide-induced
4
peroxide-induced chemotaxis
4
chemotaxis mouse
4
neutrophils directed
4
directed locomotion
4
locomotion mouse
4
neutrophils agarose
4

Similar Publications

Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models.

Front Oncol

January 2025

Departamento de Radiologia e Oncologia, Comprehensive Center for Precision Oncology (C2PO), Centro de Investigação Translacional em Oncologia (CTO), Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo (HCFMUSP), Sao Paulo, SP, Brazil.

Introduction: Intraperitoneal chemotherapy for ovarian cancer treatment has controversial benefits as most methodologies are associated with significant morbidity. We carried out a systematic review to compare tumor response, measured by tumor weight and volume, between intraperitoneal chemotherapy delivered via drug delivery systems (DDSs) and free intraperitoneal chemotherapy in animal models of ovarian cancer. The secondary aim was to assess the toxicity of DDS-delivered chemotherapy, based on changes in animal body weight.

View Article and Find Full Text PDF

Introduction: An effective vaccination policy must be implemented to prevent foot-and-mouth disease (FMD). However, the currently used vaccines for FMD have several limitations, including induction of humoral rather than cellular immune responses.

Methods: To overcome these shortcomings, we assessed the efficacy of levamisole, a small-molecule immunomodulator, as an adjuvant for the FMD vaccine.

View Article and Find Full Text PDF

inhibits -induced inflammatory response through targeting HMGB1 in mouse primary peritoneal macrophages.

Heliyon

January 2025

Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Background: () is one of the most common pathogens associated with deep fungal infection, which represents a serious threat to human health. Although high mobility group box 1 (HMGB1) plays a key role in infection, its mechanism is unclear. We aimed to explore the regulation of small-molecule non-coding RNA (miRNA) for HMGB1 in infection.

View Article and Find Full Text PDF

Chemotherapeutic therapies for cancer are frequently associated with cytotoxic side effects that can be harmful to human health, including the development of intestinal mucositis (IM). It mostly affects the gastrointestinal tract, causing ulceration, inflammation, and the formation of lesions in the colon. Surprisingly, despite the frequency of IM, therapeutic choices remain restricted.

View Article and Find Full Text PDF

Introduction: Programmed death-1 (PD-1) is a negative regulator of immune responses. Upon deletion of PD-1 in mice, symptoms of autoimmunity developed only after they got old. In a model experiment in cancer immunotherapy, PD-1 was shown to prevent cytotoxic T lymphocytes from attacking cancer cells that expressed neoantigens derived from genome mutations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!